Korro Bio, Inc.
KRRO
$6.04
$0.7614.39%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -88.42M | -91.36M | -87.41M | -83.58M | -87.81M |
| Total Depreciation and Amortization | 4.88M | 4.57M | 4.06M | 3.57M | 3.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.98M | 6.12M | 5.86M | 6.35M | 7.60M |
| Change in Net Operating Assets | 8.20M | 13.39M | 14.85M | 13.59M | 3.22M |
| Cash from Operations | -68.35M | -67.27M | -62.64M | -60.07M | -73.69M |
| Capital Expenditure | -1.89M | -6.59M | -12.41M | -17.90M | -18.11M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.20M | 12.73M | -72.55M | -105.45M | -104.13M |
| Cash from Investing | 26.31M | 6.14M | -84.96M | -123.35M | -122.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.24M | 1.84M | 69.39M | 69.36M | 222.63M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -9.62M |
| Cash from Financing | 1.24M | 1.84M | 69.39M | 69.36M | 213.01M |
| Foreign Exchange rate Adjustments | -17.00K | -15.00K | -6.00K | -6.00K | -- |
| Miscellaneous Cash Flow Adjustments | 2.00K | 2.00K | 2.00K | 2.00K | -- |
| Net Change in Cash | -40.82M | -59.31M | -78.21M | -114.07M | 17.09M |